KRT19 and carcinoma: A team from Heidelberg University summarized the immunohistochemical (IHC) features of scirrhous carcinoma, and the positive rate of HepPar-1, CK7, CK19 and EMA was 64.6%, 40.7%, 16.0%, and 41.9%, respectively (19).